Tezepelumab Granted Breakthrough Therapy Designation By US FDAAMGN : Amgen
2018-09-07 02:00:00
Tezepelumab Granted Breakthrough Therapy Designation By US FDA For The Treatment Of Patients With Severe Asthma Without An Eosinophilic Phenotype
AMGN trade ideas
Live example of a market cycle euphoria phase coming to an endWhat happens when a car keeps going forward, but slows down?
Same principle.
Here is a quick summary about market cycles:
www.investopedia.com
If 200$ was indeed the top, what we should see next are lower highs. And a long bear market.
It has already been going up with less strength for a while. Retail investors getting dumped on.
Well I say retail investors, but institutions too, they don't do anything special.
The difference is institutions will be the first to "panic" sell when shit hits the fan.
It will be too hard for retail to do, but trust me, when something is hard to do, most of the time it is a very good idea to do it.
Making the hard choices is what the masses cannot do, and being able to do that gives you an incredible edge.
That... or being logical to start with and not emotional lol... I personally fail to see the logic. That should not even be a hard decision, just binary.
Oh and by the way, having your money managed by pro's does not shield you if you invest in overvalued crap (not saying AMGEN is crap).
Novogratz crypto fund dropped by 30%, his clients money is gone.
"Strength in numbers" does not apply to finance :p
Think of it rather like cattle going to the slaughterhouse. Do they have strength in numbers?
Get ready to see Amgen feature on bagholderquotes, in a few months, by 2020 at the very most:
twitter.com
AMGN: Sort opportunityAn intraday high potential, Back Tested Sort Analysis.
We ll try to enter into the correction of the uptrend movement tracking trend oscillators as below:
Price is likely to move within the parallel channel having the potential to break it down.
A Gartley pattern is shaped signaling a bearish movement.
DETAILS ON THE CHART
NOTE: Entry range area above the entry point, is calculated upon 80% of the recorded pullback back tested past performances
DISCLAIMER: This is a technical analysis study, not an advice or recommendation to invest money on.
Head And Shoulder Pattern Formation On Amgen?Shares of Amgen may be forming a bearish head and shoulder pattern. In the case the neckline is broken, price could fall within weeks to below $150.00. However we must take into account that Amgen share price is not currently in a bearish trend, but a long bullish one. This is a pattern formation that is being put on watch, in case it breaks. Once the share price approaches the neckline, we may develop a bearish strategy.
